CurrentCardio
Get Weekly

CurrentCardio coverage · page 5 of 6

ESC Heart Failure

Briefs 161–200 of 214 CurrentCardio has covered from this journal, newest publication first

Latest from ESC Heart Failure

All coverage, newest first

  1. ESC Heart Fail

    Cardiovascular risk associated with polypharmacy in heart failure: a systematic review and meta-analysis

    Meta-analysisHeart failure

  2. ESC Heart Fail

    Global burden of heart failure due to cardiovascular diseases, 1990–2021 and predictions to 2035 based on GBD 2021

    Cohort studyHeart failure

  3. ESC Heart Fail

    Association between cumulative exposure to cardiometabolic index and risk of heart failure: a prospective cohort study

    Cohort studyHeart failure

  4. ESC Heart Fail

    Bioimpedance-derived compartmental fluid status and prognosis in chronic heart failure

    Cohort studyHeart failure

  5. ESC Heart Fail

    Long-term prognostic value of cardiopulmonary exercise testing in patients with hypertrophic cardiomyopathy

    Cohort studyHeart failure

  6. ESC Heart Fail

    Metformin inhibits proliferation of residing fibroadipogenic progenitor cells from failing human hearts

    Mechanistic studyHeart failure

  7. ESC Heart Fail

    Baseline characteristics in the TransitionCHF study: asymptomatic patients with heart failure and reduced ejection fraction

    Cohort studyHeart failure

  8. ESC Heart Fail

    The adjusted ferritin inflammation index: a novel metric for predicting mortality in heart failure with reduced and mildly reduced ejection fraction

    Cohort studyHeart failure

  9. ESC Heart Fail

    Bridging the gap in heart failure management: the effect of a cross-disciplinary intervention on guidelines-directed medical therapy in primary care

    Cohort studyHeart failure

  10. ESC Heart Fail

    Optimising Transitions of Care and Long-Term Management in Heart Failure: A Scoping Review of Strategies and Models

    Research articleHeart failure

  11. ESC Heart Fail

    Clinical risk prediction models for worsening heart failure events and all-cause mortality in adults with mild-to-moderate chronic kidney disease

    Diagnostic or prognostic studyCardiometabolic & kidney

  12. ESC Heart Fail

    Effect of mavacamten on sudden cardiac death risk scores in obstructive hypertrophic cardiomyopathy

    Cohort studyHeart failure

  13. ESC Heart Fail

    Efficacy of aficamten according to geographic location of patients with hypertrophic obstructive cardiomyopathy

    Randomised controlled trialHeart failure

  14. ESC Heart Fail

    Predicting survival in patients with heart failure aged 80 years and older

    Diagnostic or prognostic studyHeart failure

  15. ESC Heart Fail

    Prognostic performance of cardiogenic shock 4 proteins prediction model in infarct-related cardiogenic shock

    Secondary analysisAcute care & resuscitation

  16. ESC Heart Fail

    Quantifying skeletal muscle energy metabolism during exercise in heart failure with preserved ejection fraction using in vivo 31P magnetic resonance spectroscopy

    Cohort studyHeart failure

  17. ESC Heart Fail

    Adaptive blood pressure–modulated atrial pacing in hypertensive HFpEF patients: a randomized, first-in-human study

    Randomised controlled trialHeart failure

  18. ESC Heart Fail

    Arterio-venous gradient of active interleukin-18 is associated with diastolic dysfunction: a cross-sectional study

    Cross-sectional studyHeart failure

  19. ESC Heart Fail

    Effect of sodium-glucose cotransporter-2 inhibitors on haemoglobin and haematocrit levels in heart failure: a systematic review and meta-analysis

    Meta-analysisHeart failure

  20. ESC Heart Fail

    Improved performance after neuromuscular electrical stimulation in hospitalized patients with severe heart failure

    Randomised controlled trialHeart failure

  21. ESC Heart Fail

    Non-invasive cardiovascular magnetic resonance pulmonary capillary wedge pressure predicts future atrial fibrillation: a LOOP substudy

    Secondary analysisArrhythmias & EP

  22. ESC Heart Fail

    The impact of country income level on the management of heart failure with preserved ejection fraction: an international survey

    Cross-sectional studyHeart failure

  23. ESC Heart Fail

    One-year follow-up of patients with severe tricuspid regurgitation: prognostic impact of right heart failure staging

    Cohort studyValvular & structural

  24. ESC Heart Fail

    Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: primary results of the ARCHER study

    Research articleHeart failure

  25. ESC Heart Fail

    Mortality and heart failure hospitalizations in heart failure with preserved ejection fraction compared to heart failure with reduced ejection fraction: a systematic review and meta-analysis

    Meta-analysisHeart failure

  26. ESC Heart Fail

    Myocardial testosterone glucuronide and disease phenotypes in hypertrophic cardiomyopathy

    Cohort studyHeart failure

  27. ESC Heart Fail

    Rationale and design of the Pre-MYO project: a precision-medicine platform for myocarditis diagnosis and management

    Trial designHeart failure

  28. ESC Heart Fail

    The possible impact of levosimendan infusions on clinical course of heart failure: the results of the LEIA-HF study

    Randomised controlled trialHeart failure

  29. ESC Heart Fail

    Impact of maintaining mild mitral regurgitation beyond 1 year after mitral transcatheter edge-to-edge repair

    Cohort studyValvular & structural

  30. ESC Heart Fail

    Ketone bodies and incident heart failure: 20-year results from the prospective British Regional Heart Study

    Cohort studyHeart failure

  31. ESC Heart Fail

    Cardiac disease in patients with inflammatory myopathy

    Cohort studyHeart failure

  32. ESC Heart Fail

    Clinical and echocardiographic changes after intermittent levosimendan infusion in patients with advanced heart failure

    Cohort studyHeart failure

  33. ESC Heart Fail

    Independent external validation of the LIFE-HF clinical prediction model using the GUIDE-IT trial

    Diagnostic or prognostic studyHeart failure

  34. ESC Heart Fail

    Non-dilated left ventricular cardiomyopathy in patients with chronic Chagas disease and heart failure with reduced left ventricular ejection fraction

    Cohort studyHeart failure

  35. ESC Heart Fail

    Protein biomarkers associated with left bundle branch block in patients with heart failure and reduced ejection fraction

    Research articleHeart failure

  36. ESC Heart Fail

    Urinary sodium to guide diuretic therapy in acute heart failure: results of a national survey

    Cross-sectional studyHeart failure

  37. ESC Heart Fail

    Early initiation of sodium–glucose co-transporter-2 inhibitors in heart failure patients: a nationwide study

    Cohort studyHeart failure

  38. ESC Heart Fail

    Prognostic value of exercise-induced pulmonary congestion by lung ultrasound in patients with heart failure

    Diagnostic or prognostic studyHeart failure

  39. ESC Heart Fail

    Atrial fibrillation increases left and right atrial pressures in patients with chronic heart diseases

    Cohort studyArrhythmias & EP

  40. ESC Heart Fail

    Sex-related disparities in elderly patients with heart failure with mildly reduced or preserved ejection fraction

    Cohort studyHeart failure

All 214 Briefs in ExploreShowing Briefs 161–200 of 214, newest first